FDA reviewers cite Moderna flu immune data, boosting shares 6% on Tuesday
A staff assessment suggests Moderna's flu shot could work in adults 65+, shifting expectations for a key late-stage audience.
By Mohammed Al-Shehri·· 3 min
1 briefing · “moderna”
A staff assessment suggests Moderna's flu shot could work in adults 65+, shifting expectations for a key late-stage audience.